GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (FRA:LTI0) » Definitions » Total Long-Term Liabilities

Aptose Biosciences (FRA:LTI0) Total Long-Term Liabilities : €7.90 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Aptose Biosciences Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Aptose Biosciences's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was €7.90 Mil.

Aptose Biosciences Total Long-Term Liabilities Historical Data

The historical data trend for Aptose Biosciences's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Total Long-Term Liabilities Chart

Aptose Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.10 0.95 0.57 9.75

Aptose Biosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.38 9.29 9.75 7.90

Aptose Biosciences Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Aptose Biosciences Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptose Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (FRA:LTI0) » Definitions » Total Long-Term Liabilities
Comparable Companies
TSXV:QPT XCNQ:ASEP TSXV:XRTX XCNQ:LOBE TSXV:RKV TSXV:MRVL TSXV:KNE XCNQ:GLOW XCNQ:MYND XCNQ:NURL VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
APTOF:USA 0UI8:UK APS:Canada
Address
66 Wellington Street West, Suite 5300, TD Bank Tower Box 48, Toronto, ON, CAN, M5K 1E6
Website
https://www.aptose.com
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Aptose Biosciences Headlines

No Headlines